Asymmetric occluder device
11197660 · 2021-12-14
Assignee
Inventors
Cpc classification
A61B17/0057
HUMAN NECESSITIES
A61B2017/00606
HUMAN NECESSITIES
A61B2017/00575
HUMAN NECESSITIES
International classification
Abstract
An asymmetric occlusion device for occluding an opening in a body tissue where part of the opening is defined by a partial inadequate rim. The asymmetric occlusion device includes a waist portion having a distal end extending to a proximal end. The waist portion is of non-woven material extending around a longitudinal axis opening. The occlusion device further includes a pair of asymmetric occluder disks attached to the waist. The asymmetric distal and proximal occluder disks are formed of shape memory material. The asymmetric occluder disks include a short arm extending from the waist and an extended arm extending from the waist. The extended arm exceeds the length of the first short arm. The density of the first short arm exceeds the density of the second extended arm.
Claims
1. A method of occluding a septal defect in a septum comprising: inserting a delivery catheter containing a septal occluder through the septal defect releasably attached to a hub in which wire ends of a braiding are gathered, said braiding forming a first disk and a second disk of said septal occluder, said first disk and said second disk joined together by a waist, and said hub is off-center of said waist, thereby creating a narrow portion on one side of the hub and a wide portion on an opposite side of the hub; expanding said first disk from a distal end of the catheter on a distal side of the septum; expanding said second disk from the distal end of the catheter on a proximal side of the septum, thereby squeezing the septum between the first disk and the second disk; wherein said off-center hub causes said delivery catheter to become displaced laterally from said septal defect prior to release; releasing said occluder from said delivery catheter by detaching from the catheter said hub.
2. The method of claim 1 further comprising providing an additional magnetic force between the first disk and the second disk.
3. The method of claim 1 wherein releasing the occluder comprises unthreading a snare wire that is threaded through an opening through the hub.
4. The method of claim 1 wherein expanding said second disk from the distal end of the catheter on a proximal side of the septum, thereby squeezing the septum between the first disk and the second disk comprises providing a torsional rotation of the first and second disk.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
DETAILED DESCRIPTION OF THE INVENTION
(16) The present invention provides a device for occluding an aperture within body tissue wherein the aperture includes an area of adequate rim and an area of inadequate rim.
(17)
(18) Occluder (or occlusion) devices are known for occluding ASDs. Reference is made to U.S. Patent Publication 2009/0228038 to Amin for one such heart occluder device. However, such devices are typically symmetrical occluders which are able to repair a defect having adequate rim structure completely encircling the defect. By “adequate rim structure,” it is meant that there is a sufficient amount of tissue making up the rim and surrounding tissue of the heart wall to accept an occluder device.
(19) Unfortunately, there are times when the heart defect does not occur in a more centrally located area of the septum 22, but rather at the edge of the septum 22 as illustrated in
(20) As used herein, “distal” refers to the direction away from the delivery catheter and “proximal” refers to the direction nearer the delivery catheter.
(21) As used herein, “memory” or “shape memory” refers to a property of materials to resume and maintain an intended shape despite being distorted for periods of time, such as during storage or during the process of delivery in viva.
(22) Reference is now made to
(23) Unlike the prior art occluder device 102 described above, the septal occluder device 100 of the present invention is distinguished by extended distal and proximal disks 120, 122 which include an extended arm 110 thereby giving each disk 120, 122 an ovoid or oval appearance. In addition, the waist 105 separating the disks 120, 122 is ovoid in shape to accommodate the shape of the disks 120, 122. The disks 120, 122 are further defined by having the hub area 107 offset thus forming a short arm 112 opposing the extended arm 110. As illustrated by arrows 114 and 116, the length or radius of the short arm 112 is shorter than the length or radius of the extended arm 110. As will be illustrated and described in this disclosure, the extended arm 110 in combination with the unique features of the short arm 112 will create a device for adequately occluding an aperture 20 in the heart septum 22 which is characterized by an inadequate rim structure 28. As illustrated in
(24) Referring now to
(25) In certain embodiments, the memory may also assist in pressing the aperture 20 closed. The diameter or thickness of the wire depends on the size and type of the device, i.e., the larger the device, the larger the diameter of the wire. In general, wire having a diameter between about 0.2 mm and 0.8 mm can be used.
(26) Each disk 120, 122 in the occluder device 100 includes a rim 124, 126, also made of shaped memory material to create and hold the ovoid shape of each disk 120, 122 as illustrated. While the ovoid shape is illustrated and is the preferred shape for the device 100 of the present invention, it is within the scope to have other shapes as desired. Ideally, the shape of the disks 120, 122 is customized to approximate the size and shape of the ASD.
(27) As illustrated primarily in
(28) The disks 120, 122 are shaped and constructed of a dense mesh of tightly woven wire material, such as nitinol. The form of the distal disk 120 opposes the form of the proximal disk 122 and is connected by a 3-4 mm short ovoid waist 105, illustrated in
(29) As illustrated in
(30) In addition to acting as a stopper for the ASD 20, the waist acts to retain the occluder disks 120, 122 in place on the ASD 20 for maximum sealing. Further, the waist 105 assists in preventing the inadvertent or accidental displacement of the occluder device 100.
(31) The short arm 112 of each disk 120, 122 is defined by an arcuate portion 126, 128 in each rim 124, 125, and is designed to attach or clamp onto the rim 25 of the aperture 20 defined by the adequate rim 26.
(32) Likewise, the extended arm 110 of each disk 120, 122 is defined by an arcuate portion 130, 132 in each rim 124, 125. This arm is intended to attach or clamp onto the rim 25 of the aperture 20 defined by the inadequate rim 28.
(33) To assist in accomplishing this task, the short arm 112 is characterized by increased bulk or thickness density of memory material, illustrated by the dense mesh of memory material 134, to increase the size, structure, strength and tension of each disk 120, 122 at the region of the short arm 112. The added bulk can be accomplished by adding more memory material, such as memory wire, thicker wire, or a combination of both. Without wishing to be restricted to any set dimensions, the preferred thickness of the short arm, illustrated by arrow 136 in
(34) Referring now to
(35) It is also within the scope of the present invention to add a mild magnetic property to occluder device 100 at the short arm 112 of each disk 120, 122. The magnetic property is specifically placed on the wire mesh on the interior surfaces 150, 152 adjacent the adequate rim 26 area of the septum 20. Applying a mild magnetic property to each disk 120, 122 will aid in attracting each disk 120, 122 to each other for more secure closure over the adequate rim 26. This in turns adds closure pressure at the extended arm 110 portion of the disk thereby assisting the ends 130, 132 in a proper sealing closure on the inadequate rim 28. This effectively seals the aperture 20 without any displacement. Therefore, when both of the disks 120, 122 are deployed, the magnetic property causes the two disks 120, 122 to be kept attached to each other at the safe and firm part of the septum 22. As illustrated in
(36) Referring now to the hub 107 located in the center of the waist 105, the hub 107 is defined by an extension 108, located on both surfaces of the distal occluder disk 120 and proximal occluder disk 122. As illustrated in
(37) The occluder device 100 may also include a scaffold or sealed covering 111, illustrated in
(38) The deployment of the occluder device 100 is well-known to the art and similar to standard Amplatzer-type deployment steps. It is typically a percutaneous procedure which does not require major surgery.
(39) Referring to
(40) Referring to
(41) Referring to
(42) Referring to
(43) Referring to
(44) Properly placed, the occluder device 100 will stay in place for the life of the patient. As the occluder device 100 becomes further embedded into the septum 22 tissue, new tissue will grow over the occluder device 100 further securing the occluder device 100 to the septum 22.
(45) The occluder device 100 is connected to a hub 107, which includes a delivery attachment mechanism for attachment to a deployment cable 32 housed within a delivery catheter sheath or catheter 33.
(46) Therefore, one, two or three of the following parameters can help the occluder device 100 seat properly in place without prolapse into the right atrium 12:
(47) a. The extra length of the distal and proximal disks 120, 122 on the side with inadequate rim 28;
(48) b. The added thickness or density of the short arms 112 of both the distal and proximal disks 120, 122; and
(49) c. The equal size of the distal and proximal disk members 120, 122 which provides better support, especially considering the firmer wire mesh and the larger retention disc member on part of the disc member that seats on the part of the septum 22 with the adequate rim 28.
(50) In the event, the occluder device 100 must be removed for any reason, such as an inadvertent embolism, the channel 109 within the extension in the hub 108 in the occluder device 100 is useful for this process. The channel 109 within the extension 108 facilitates retrieving the occluder device 100 on both the left atrium 12 and right atrium 14 sides by passing an appropriate guide wire through the channel 109 and snaring the proximal disk 122.
(51) Referring to
(52) Referring to
(53) Any version of any component or method step of the invention may be used with any other component or method step of the invention. The elements described herein can be used in any combination whether explicitly described or not.
(54) All combinations of method steps as used herein can be performed in any order, unless otherwise specified or clearly implied to the contrary by the context in which the referenced combination is made.
(55) As used herein, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise.
(56) Numerical ranges as used herein are intended to include every number and subset of numbers contained within that range, whether specifically disclosed or not. Further, these numerical ranges should be construed as providing support for a claim directed to any number or subset of numbers in that range. For example, a disclosure of from 1 to 10 should be construed as supporting a range of from 2 to 8, from 3 to 7, from 5 to 6, from 1 to 9, from 3.6 to 4.6, from 3.5 to 9.9, and so forth.
(57) All patents, patent publications, and peer-reviewed publications (i.e., “references”) cited herein are expressly incorporated by reference in their entirety to the same extent as if each individual reference were specifically and individually indicated as being incorporated by reference. In case of conflict between the present disclosure and the incorporated references, the present disclosure controls.
(58) The devices, methods, compounds and compositions of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations described herein, as well as any additional or optional steps, ingredients, components, or limitations described herein or otherwise useful in the art.
(59) While this invention may be embodied in many forms, what is described in detail herein is a specific preferred embodiment of the invention. The present disclosure is an exemplification of the principles of the invention is not intended to limit the invention to the particular embodiments illustrated. It is to be understood that this invention is not limited to the particular examples, process steps, and materials disclosed herein as such process steps and materials may vary somewhat. It is also understood that the terminology used herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope of the present invention will be limited to only the appended claims and equivalents thereof.
BIBLIOGRAPHY
(60) Amin Z., “Transcatheter closure of secundum atrial septal defects,” Catheter Cardiovasc. Interv., 2006 November: 68(5):778-87. Review. Gokaslan G., Ustunsoy H., Deniz H., Ozcaliskan O., Yasim A., Baspinar O. and G. Guzel, “Urgent surgical management for embolized occluder devices in childhood: single center experience,” J. Cardiothorac. Surg., 2012 Dec. 7; 7:127. Kannan, B. R., Francis E., Sivakumar K., Anil S R. and R. K. Kumar, “Transcatheter closure of very large (> or =25 mm) atrial septal defects using the Amplatzer septal occluder,” Catheter Cardiovasc. Interv., 2003 August: 59(4):522-7. Kazmouz, S., Kenny, D., Cao, Q., Kavinsky, C. J. and Z. M. Hijazi, “Transcatheter Closure of Secundum Atrial Septal Defects,” J. Invasive Cardiol., 2013; 25(5); 257-264.s King, T. D., Thompson, S. L., Steiner, C. and N. L. Mills, “Secundum Atrial Septal Defect: Nonoperative Closure During Cardiac Catheterization,” JAMA 1976; 235 (23): 2506-2509. King T. D. and N. L. Mills, Chapter 4: Historical perspectives on ASD device closure. In: Hijazi, Z. M.; Feldman, T., Al-Qbandi, M. A. and H. Sievert (eds) Transcatheter Closure of ASDs and PFOs, A Comprehensive Assessment, Minneapolis, Minn.: Cardiotext Publishing; 2010: 37-64. Knirsch W., Dodge-Khatami A., Valsangiacomo-Buechel E., Weiss M. and F. Berger, “Challenges encountered during closure of atrial septal defects,” Pediatric Cardiology, 2005: 26(2): 147-153. Li G. S., Li H. D., Yang J., Zhang W. Q, Hou Z. S., Li Q. C. and Y. Zhang, “Feasibility and safety of transthoracic echocardiography-guided transcatheter closure of atrial septal defects with deficient superior-anterior rims,” PLoS One, 2012 Dec. 17; 7(12):e51117. Love B. A., Bock M. and S. Srivastava, “Advantages of the GORE® HELEX® Septal Occluder for Closure of Atrial Septal Defect with a Deficient Retroaortic Rim,” Closing Remarks, 2012 Summer, XIX, 1-3, Gore Medical. Moore J., Hegde S., E I-Said H., Beekman R. 3rd, Benson L., Bergersen L., Holzer R., Jenkins K., Ringel R., Rome J., Vincent R. and G. Martin, “Transcatheter device closure of atrial septal defects: a safety review,” JACC Cardiovasc. Interv., 2013 May: 6(5):433-42. Podnar T., Martanovic P., Gavora P. and J. Masura, “Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders,” Catheter Cardiovasc. Interv., 2001 July; 53(3):386-91.